| Songlin Liang, MD | |
|
155 Crystal Run Rd, Middletown, NY 10941-4028 | |
| (845) 703-6999 | |
| (845) 703-6297 |
| Full Name | Songlin Liang |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 39 Years |
| Location | 155 Crystal Run Rd, Middletown, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023195880 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensackumc Mountainside | Montclair, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| As Medical Pc | 1951561950 | 2 |
| Pathlink Of New Jersey | 0446641245 | 15 |
News Archive
It is important to understand what biological mechanisms contribute to an individual's capacity to be resilient under conditions of extreme stress, such as those regularly experienced by soldiers, police, and firefighters.
New research, to be revealed on Tuesday 26th of April at the launch of the University of Warwick Medical School's new Clinical Sciences Research Institute at the University Hospital campus at Walsgrave in Coventry, has shown that very simple interventions to target the health care of UK Asian diabetics can almost wipe out the 40% higher risks of heart disease linked to diabetes in that community.
Researchers have found positive immunostaining of α-synuclein in the enteric nervous system of patients with idiopathic rapid eye movement sleep behaviour disorder, suggesting it may have a possible role as a biomarker for prodromal Parkinson's disease.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today reported its financial results for the second quarter and six months ended June 30, 2013.
› Verified 6 days ago
| Entity Name | As Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063787067 PECOS PAC ID: 1951561950 Enrollment ID: O20120329000111 |
News Archive
It is important to understand what biological mechanisms contribute to an individual's capacity to be resilient under conditions of extreme stress, such as those regularly experienced by soldiers, police, and firefighters.
New research, to be revealed on Tuesday 26th of April at the launch of the University of Warwick Medical School's new Clinical Sciences Research Institute at the University Hospital campus at Walsgrave in Coventry, has shown that very simple interventions to target the health care of UK Asian diabetics can almost wipe out the 40% higher risks of heart disease linked to diabetes in that community.
Researchers have found positive immunostaining of α-synuclein in the enteric nervous system of patients with idiopathic rapid eye movement sleep behaviour disorder, suggesting it may have a possible role as a biomarker for prodromal Parkinson's disease.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today reported its financial results for the second quarter and six months ended June 30, 2013.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Songlin Liang, MD 155 Crystal Run Rd, Middletown, NY 10941-4028 Ph: (845) 703-6999 | Songlin Liang, MD 155 Crystal Run Rd, Middletown, NY 10941-4028 Ph: (845) 703-6999 |
News Archive
It is important to understand what biological mechanisms contribute to an individual's capacity to be resilient under conditions of extreme stress, such as those regularly experienced by soldiers, police, and firefighters.
New research, to be revealed on Tuesday 26th of April at the launch of the University of Warwick Medical School's new Clinical Sciences Research Institute at the University Hospital campus at Walsgrave in Coventry, has shown that very simple interventions to target the health care of UK Asian diabetics can almost wipe out the 40% higher risks of heart disease linked to diabetes in that community.
Researchers have found positive immunostaining of α-synuclein in the enteric nervous system of patients with idiopathic rapid eye movement sleep behaviour disorder, suggesting it may have a possible role as a biomarker for prodromal Parkinson's disease.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today reported its financial results for the second quarter and six months ended June 30, 2013.
› Verified 6 days ago
Samuel Louie, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 707 E Main St, Orange Regional Medical Center, Middletown, NY 10940 Phone: 845-333-0089 Fax: 201-661-7297 | |
Juan Dardati, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: Orange Regional Medical Center - Horton Campus, 60 Prospect Ave, Middletown, NY 10940 Phone: 845-342-7156 | |
Kelly Herrera, MD Pathology Medicare: Medicare Enrolled Practice Location: Orange Regional Medical Center - Horton Campus, 60 Prospect St, Middletown, NY 10940 Phone: 845-294-4339 Fax: 845-294-4333 | |
Dr. Min Guo, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999 Fax: 845-703-6297 | |
Thomas Stockl, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 707 E Main St, Middletown, NY 10940 Phone: 201-256-4247 | |
Cherif Ibrahim, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 60 Prospect Avenue, Mid Atlantic Pathology Services, Pa/orange Regional Med, Middletown, NY 10940 Phone: 845-346-0664 |